The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
俄勒冈州立大学临床和转化科学中心:推进当今的发现以改善健康
基本信息
- 批准号:10705933
- 负责人:
- 金额:$ 562.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-22 至 2030-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAppalachian RegionApplied ResearchCOVID-19ClinicalClinical ResearchClinical SciencesClinical and Translational Science AwardsCollaborationsCommunitiesDataData ScienceData SetDecision MakingDemocracyDevelopmentDisciplineDisparityDissemination and ImplementationEducationEffectivenessEnsureEnvironmentEquityFacultyFoundationsFundingGrantGrowthHealthHealthcareHumanIndividualIndustryInfantInfrastructureInstitutionInvestmentsKnowledgeLeadershipLeftLife Cycle StagesMaternal MortalityMedical centerMethodsOhioOutcomes ResearchPatientsPediatric HospitalsPopulationProcessPublic HealthRacial injusticeReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResearch DesignResearch PersonnelResource InformaticsResourcesRuralScienceSystemSystems IntegrationThinkingTrainingTraining SupportTraining and EducationTranslational ResearchUniversitiesValidationVisionVoiceWorkcareer developmentclinical centerclinical translationclinically relevantcollegecommunity engaged researchcomplex datacomputing resourcescostdata accessdemographicshealth care deliveryhealth disparityhealth equityimplementation scienceimprovedinnovationlensmembermulti-site trialnovel strategiesopioid epidemicresponseskillssocialsocial health determinantstooltranslational pipeline
项目摘要
ABTRACT
The Ohio State University (OSU) Center for Clinical and Translational Science (CCTS) was formed in 2007,
with the vision to advance today’s discoveries to improve health for all. We employed a comprehensive
approach to address the full spectrum of T1-T4 science via the education and career development of a highly
trained workforce integrated with a robust system of CTR resources. We provided leadership in the CTSA
Consortium through sharing of tools and methods to advance CTR; adopted innovations from other hubs; and
fully engaged in CTSA Consortium activities (e.g., multisite trials). We also supported community engaged
research addressing the most pressing health issues in our communities (e.g., opioid crisis, COVID-19). Yet,
work remains. Thus, we build upon unique strengths at OSU/NCH and in Ohio’s communities. We have
leveraged our strategic investment in data sciences, a robust environment of resources, and a vibrant CTR
community to address CTS gaps and barriers. We will now address five CTS roadblocks to improve the
quality, efficiency, and rigor of CTR: (1) need for improved efficiencies and effectiveness to advance CTR and
ensure results are disseminated and implemented into healthcare; 2) education and training innovations do not
reach the full CTR workforce, resulting in a declining and inadequately diverse CTS workforce, lacking the
knowledge and skills to advance CTR; 3) limited authentic participation by diverse stakeholders across the
research life cycle; 4) growth of complex datasets necessitates integration of clinical, environmental, and
research data, with need for democratization of data accessibility to advance data equity; and 5) racial injustice,
SDoH, the CTR teams we form, and interpretation of our results impact health disparities. Applying a health
equity and DEIA framework to every activity, we will pursue five aims: Aim 1: Develop innovations in
methods, approaches, and tools to address pressing roadblocks facing CTR. Aim 2: Support training and
career development of the full CTS workforce. Aim 3: Engage voices from across academic and scientific
disciplines, patients, communities, and industry to conduct CTR and CTS across the full lifecycle of the scientific
process. Aim 4: Deploy an accessible, responsive, and integrated system of research resources. Aim 5:
Democratize informatics resources by lowering the cost of entry for data access and computing resources. With
a commitment to metric-driven decision-making, we will evaluate the impact of the CCTS by applying the RE-
AIM framework to inform strategic pivots over the next 7 years. This proposal reaffirms our commitment to
advance CTS and expands our engagement with stakeholders to increase rigorous, impactful, and relevant
CTR. We will develop, share, and adopt innovations through focused CTS to enhance CTR for the communities
we serve and those we engage. These resources, skilled workforce, and institutional strengths provide an agile
foundation to facilitate rapid responses to emerging public health issues, and will ensure an equity lens is
applied to all CTR so no one is left behind from the advances of CTR to improve human health.
摘要
俄亥俄州立大学 (OSU) 临床和转化科学中心 (CCTS) 成立于 2007 年,
我们的愿景是推进今天的发现,改善所有人的健康。
通过高度重视的教育和职业发展来解决 T1-T4 科学的全部问题
我们在 CTSA 中发挥了领导作用。
联盟通过共享工具和方法来提高点击率;
充分参与 CTSA 联盟活动(例如,多站点试验) 我们还支持社区参与。
研究解决我们社区最紧迫的健康问题(例如阿片类药物危机、COVID-19)。
因此,我们依靠 OSU/NCH 和俄亥俄州社区的独特优势。
利用我们在数据科学方面的战略投资、强大的资源环境以及充满活力的点击率
我们现在将解决五个 CTS 障碍,以改善 CTS 的差距和障碍。
CTR 的质量、效率和严格性:(1) 需要提高效率和有效性,以提高 CTR 和
确保结果得到传播并落实到医疗保健领域;2) 教育和培训创新不
覆盖全部 CTR 员工队伍,导致 CTS 员工队伍不断减少且多元化不足,缺乏
提高点击率的知识和技能;3) 不同利益相关者的真实参与有限;
研究生命周期;4) 复杂数据集的增长需要整合临床、环境和
研究数据,需要实现数据可访问性的民主化,以促进数据公平;5) 种族不平等,
SDoH、我们组建的 CTR 团队以及对我们结果的解释都会影响健康差异。
我们将公平和 DEIA 框架融入到每项活动中,我们将追求五个目标: 目标 1:在以下方面发展创新:
解决 CTR 面临的紧迫障碍的方法、途径和工具 目标 2:支持培训和培训。
目标 3:吸引来自学术界和科学界的声音。
学科、患者、社区和行业在科学的整个生命周期中进行 CTR 和 CTS
目标 4:部署可访问、响应迅速且集成的研究资源系统。
通过降低数据访问和计算资源的进入成本来实现信息学资源的民主化。
为了致力于度量驱动的决策,我们将通过应用 RE- 来评估 CCTS 的影响
AIM 框架为未来 7 年的战略支点提供信息 该提案重申了我们的承诺。
CTS 并扩大我们与利益相关者的接触,以提高严谨性、影响力和相关性
CTR。我们将通过重点 CTS 开发、分享和采用创新,以提高社区的 CTR。
我们服务的对象以及我们参与的对象。这些资源、熟练的劳动力和机构优势提供了敏捷性。
基金会,以促进对新出现的公共卫生问题的快速反应,并将确保公平的视角
应用于所有 CTR,因此没有人会因 CTR 改善人类健康的进步而落后。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Social Media Use and Its Concurrent and Subsequent Relation to a Biological Marker of Inflammation: Short-Term Longitudinal Study.
- DOI:10.2196/46309
- 发表时间:2023-12-08
- 期刊:
- 影响因子:7.4
- 作者:Lee, David;Jiang, Tao;Crocker, Jennifer;Way, Baldwin
- 通讯作者:Way, Baldwin
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CYNTHIA A GERHARDT其他文献
CYNTHIA A GERHARDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CYNTHIA A GERHARDT', 18)}}的其他基金
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10524167 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Moderating Role of Sibling Relationships (Diversity Supplement for D. Garcia)
早发儿科癌症年轻幸存者的心理社会风险:兄弟姐妹关系的调节作用(D. Garcia 的多样性补充)
- 批准号:
10381330 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10348200 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10737753 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10771642 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Moderating Role of Residential Location (Diversity Supplement for V. Patterson)
早发儿科癌症年轻幸存者的心理社会风险:居住地点的调节作用(V. Patterson 的多样性补充)
- 批准号:
10382011 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10524166 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10608131 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Sibling and Parent Bereavement from Childhood Cancer
因儿童癌症而失去兄弟姐妹和父母
- 批准号:
6973660 - 财政年份:2005
- 资助金额:
$ 562.3万 - 项目类别:
Sibling and Parent Bereavement from Childhood Cancer
因儿童癌症而失去兄弟姐妹和父母
- 批准号:
7618250 - 财政年份:2005
- 资助金额:
$ 562.3万 - 项目类别:
相似国自然基金
锶银离子缓释钛表面通过线粒体自噬调控NLRP3炎症小体活化水平促进骨整合的机制研究
- 批准号:82301139
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
万寿菊黄酮通过MAPK/Nrf2-ARE通路缓解肉鸡肠道氧化应激损伤的作用机制
- 批准号:32302787
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道菌群及其代谢产物通过mRNA m6A修饰调控猪肉品质的机制研究
- 批准号:32330098
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
PUFAs通过SREBPs提高凡纳滨对虾低盐适应能力的机制研究
- 批准号:32303021
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
EGLN3羟化酶通过调控巨噬细胞重编程促进肺癌细胞EMT及转移的机制研究
- 批准号:82373030
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Social and biological determinants of pregnancy-related mortality and morbidity among rural, underserved women
农村、服务不足的妇女中妊娠相关死亡率和发病率的社会和生物决定因素
- 批准号:
10676160 - 财政年份:2020
- 资助金额:
$ 562.3万 - 项目类别:
Social and biological determinants of pregnancy-related mortality and morbidity among rural, underserved women
农村、服务不足的妇女中妊娠相关死亡率和发病率的社会和生物决定因素
- 批准号:
10066601 - 财政年份:2020
- 资助金额:
$ 562.3万 - 项目类别:
Social and biological determinants of pregnancy-related mortality and morbidity among rural, underserved women
农村、服务不足的妇女中妊娠相关死亡率和发病率的社会和生物决定因素
- 批准号:
10461098 - 财政年份:2020
- 资助金额:
$ 562.3万 - 项目类别:
Appalachian Center for Cellular transport in Obesity Related Disorders (ACCORD) Genomics and Bioinformatics Core
阿巴拉契亚肥胖相关疾病细胞运输中心 (ACCORD) 基因组学和生物信息学核心
- 批准号:
10460403 - 财政年份:2018
- 资助金额:
$ 562.3万 - 项目类别: